41st EORTC –PAMM winter meeting: February 13th-15th, 2020 in Stockholm
febbraio 15, 2020
We are the people
Here you can connect and read few words about our proud AIRC Start-up Unit team – who we are, what we are proud of, aspirations and future plans!
Elisa Giovannetti
Principal InvestigatorMy research is focusing on the study of the mechanism of action, toxicity and efficacy of anticancer agents, as well as in the field of clinical pharmacology of chemotherapeutic drugs, including modeling of pharmacogenetic studies, mostly in pancreas and lung cancer…
Team picture, Cancer Pharmacology Lab, Pisa, October 2014, Dr. Giovannetti (PI), with the oncologist Sara Caponi, the surgeon Fabio Caniglia, the biologist Niccola Funel, and the student Edvige Puglisi
PhDs, technicians and clinicians participating to collaborative studies within our team
Niccola Funel
Studies on primary cancer cell cultures, laser-microdissection and tissue microarrays
Ingrid Garajova
MicroRNA as predictive an prognostic biomarkers in solid tumors
Rocco Sciarrillo
Splicing alterations as novel mechanism of drug resistance
Tessa Le Large
Phosphoproteomics for therapy response prediction in pancreatic cancer
Laura Meijer
Novel diagnostic and predictive biomarkers in liquid biopsies for peri-ampullary tumors
Chiara Caparello
Folfirinox in pancreatic cancer: clinical and translational studies towards personalized tratements
Nele van der Steen
New drug combinations and biomarkers for therapies targeting c-Met and EGFR in Non-Small Cell Lung cancer
Alessandro Leonetti
Resistance mechanisms to EGFR-TKIs non-small cell lung cancer
Mjriam Capula
Evaluation of liquid biopsies and tumor-educated platelet profiles for screening and monitoring of pancreatic cancer
Giulia Mantini
Bioinformatics studies on genomic and proteomic biomarkers in pancreatic cancer and liquid biopsies
Ornella Randazzo
Design of SF3B1 subunit modulators of the SF3B spliceosome complex
Cecilia Bergonzini
Integrative mechanobiology and genomics profiling of resistance patterns to foster novel therapeutics in pancreatic cancer
Giovanna Li Petri
Synthesis and biological evaluation of new thiadiazole derivatives as anticancer and antibiofilm agents
Btissame El Hassouni
Novel therapeutics in pancreatic cancer treatment
Alessandro Gregori
Integrative mechanobiology and genomics profiling of resistance patterns to foster novel therapeutics in pancreatic cancer
Pei Pei Che
Assessing innovative radiotherapeutic strategies in appropriate preclinical models of pancreatic ductal adenocarcinoma
Lenka Boyd
Novel biomarkers and Artificial Intelligence studies for periampullary tumors
Andrea Valles
Interrogating the (phospho)-proteome for the selection of target candidates and (non-toxic) drug combinations in pancreatic cancer
Heling Wang
Oral microbiota confers multiple levels of chemoresistance in pancreatic cancer
Giulia Bononi
Synthesis and biological evaluation of MAGL inhibitors as potential anticancer agents
Ana Katrina Mapanao
Assessment of nanoparticle-based systems for cancer therapy
Daniela Massinhia
Role of mTOR and Akt pathway in triple negative breast cancer and pancreatic cancer
Latest news
-
-
Breastfeeding during R-CHOP chemotherapy: please abstain!
settembre 11, 2019
